Pure Global
NCT04419220

Reproducibility of Flow Measurements in the SMA Using Doppler Ultrasound

Evaluating Reproducibility of Flow Measurements in the Superior Mesenteric Artery in Healthy Male Subjects Using Doppler Ultrasound
Universitaire Ziekenhuizen Leuven·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Ultrasound
Drug/Device/Intervention
Doppler Ultrasound
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Universitaire Ziekenhuizen Leuven
Location
Leuven, Belgium
Timeline & enrollment
Phase
N/A
Start date
May 27, 2019
End date
Jul 04, 2019
Enrollment
15 participants
Primary outcome

Intra-period reproducibility of flow measurements,Intra-period reproducibility of flow measurements,Inter-period reproducibility of flow measurements,Inter-observer reproducibility of flow measurements,Inter-observer reproducibility of flow measurements

Summary

This will be a single center, methodological study in healthy male subjects to evaluate the
 intra-period, inter-period and inter-observer reproducibility of flow measurements in the
 superior mesenteric artery, using Doppler Ultrasound.

ICD-10 classifications
Abnormal ultrasonic finding on antenatal screening of motherAntenatal screening for malformations using ultrasound and other physical methodsAntenatal screening for fetal growth retardation using ultrasound and other physical methodsOther diagnostic agentsExamination of ears and hearing
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04419220
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04419220 through Pure Global AI's free database. This phase not specified trial is sponsored by Universitaire Ziekenhuizen Leuven and is currently Completed. The study focuses on Ultrasound. Target enrollment is 15 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.